Effect of serine and tyrosine phosphorylation on retroviral proteinase substrates.

Vimentin, a cellular substrate of HIV type 1 (HIV-1) proteinase, contains a protein kinase C (PKC) phosphorylation site at one of its cleavage sites. Peptides representing this site were synthesized in P2 Ser-phosphorylated and nonphosphorylated forms. While the nonphosphorylated peptide was a fairly good substrate of the enzyme, phosphorylation prevented hydrolysis. Phosphorylation of human recombinant vimentin by PKC prevented its processing within the head domain, where the phosphorylation occurred. Oligopeptides representing naturally occurring cleavage sites at the C-terminus of the Rous sarcoma virus integrase were assayed as substrates of the avian proteinase. Unlike the nonphosphorylated peptides, a Ser-phosphorylated peptide was not hydrolyzed by the enzyme at the Ser-Pro bond, suggesting the role of previously established phosphorylation in processing at this site. Ser-phosphorylated and Tyr-phosphorylated forms of model substrates were also tested as substrates of the HIV-1 and the avian retroviral proteinases. In contrast to the moderate effect of P4 Ser phosphorylation, phosphorylation of P1 Tyr prevented substrate hydrolysis by HIV-1 proteinase. Substrate phosphorylation had substantially smaller effects on the hydrolysis by the avian retroviral proteinase. As the active retroviral proteinase as well as various protein kinases are incorporated into mature virions, substrate phosphorylation resulting in attenuation or prevention of proteolytic processing may have important consequences in the regulation of the retroviral life cycle as well as in virus-host cell interactions.

[1]  A Wlodawer,et al.  Analysis of substrate interactions of the Rous sarcoma virus wild type and mutant proteases and human immunodeficiency virus-1 protease using a set of systematically altered peptide substrates. , 1992, The Journal of biological chemistry.

[2]  V. Vogt,et al.  Primary structure of p19 species of avian sarcoma and leukemia viruses , 1985, Journal of virology.

[3]  J. Mellors Closing in on human immunodeficiency virus–1 , 1996, Nature Medicine.

[4]  S. Oroszlan,et al.  The preparation and biochemical characterization of intact capsids of equine infectious anemia virus. , 1989, Biochemical and biophysical research communications.

[5]  A. Tomasselli,et al.  Specificity of retroviral proteases: an analysis of viral and nonviral protein substrates. , 1994, Methods in enzymology.

[6]  D. Grandgenett,et al.  Phosphorylation of the avian retrovirus integration protein and proteolytic processing of its carboxyl terminus , 1991, Journal of virology.

[7]  Wen-Chuan Lee,et al.  Autophosphorylation-dependent protein kinase phosphorylates Ser25, Ser38, Ser65, Ser71, and Ser411 in vimentin and thereby inhibits cytoskeletal intermediate filament assembly , 1994, Journal of protein chemistry.

[8]  A. Wlodawer,et al.  Structure-based inhibitors of HIV-1 protease. , 1993, Annual review of biochemistry.

[9]  M. Inagaki,et al.  Domain- and sequence-specific phosphorylation of vimentin induces disassembly of the filament structure. , 1989, Biochemistry.

[10]  A Wlodawer,et al.  Mutations that alter the activity of the Rous sarcoma virus protease. , 1992, The Journal of biological chemistry.

[11]  P. Traub,et al.  Proteolysis of vimentin and desmin by the Ca2+-activated proteinase specific for these intermediate filament proteins , 1983, Molecular and cellular biology.

[12]  D. Grandgenett,et al.  Structural characterization of the avian retrovirus reverse transcriptase and endonuclease domains. , 1985, The Journal of biological chemistry.

[13]  N. Nakamura,et al.  Purification and characterization of a vimentin-specific protease in mouse myeloid leukemia cells. Regulation during differentiation and identity with cathepsin G. , 1992, European journal of biochemistry.

[14]  A. Skalka,et al.  Proteolytic processing of avian sarcoma and leukosis viruses pol-endo recombinant proteins reveals another pol gene domain , 1987, Journal of virology.

[15]  T. Smithgall,et al.  Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[16]  A. Wlodawer,et al.  [14]Subsite preferences of retroviral proteinases , 1994 .

[17]  T. Copeland,et al.  In situ processing of a retroviral nucleocapsid protein by the viral proteinase. , 1991, Protein engineering.

[18]  D. Trono,et al.  HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator , 1995, Cell.

[19]  A. Berger,et al.  On the size of the active site in proteases. I. Papain. , 1967, Biochemical and biophysical research communications.

[20]  R. Shoeman,et al.  Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[21]  V. Vogt,et al.  Analysis of Rous sarcoma virus Gag protein by mass spectrometry indicates trimming by host exopeptidase , 1996, Journal of virology.

[22]  G. Yu,et al.  Phosphorylation of HIV-1 gag proteins by protein kinase C. , 1993, The Journal of biological chemistry.

[23]  H. Demuth,et al.  Substrates containing phosphorylated residues adjacent to proline decrease the cleavage by proline-specific peptidases. , 1996, Biochimica et biophysica acta.

[24]  J. Louis,et al.  Autoprocessing of the HIV-1 protease using purified wild-type and mutated fusion proteins expressed at high levels in Escherichia coli. , 1991, European journal of biochemistry.

[25]  S. Tsuyama,et al.  Numerous phosphates of microtubule-associated protein 2 in living rat brain. , 1987, The Journal of biological chemistry.

[26]  V. Kostka,et al.  Specificity studies on retroviral proteinase from myeloblastosis-associated virus. , 1991, Biochemistry.

[27]  V. Kostka,et al.  Hydrolysis of synthetic chromogenic substrates by HIV-1 and HIV-2 proteinases. , 1990, Biochemical and biophysical research communications.

[28]  I. Weber,et al.  Molecular dynamics simulations of HIV-1 protease with peptide substrate. , 1994, Protein engineering.

[29]  D. Baltimore,et al.  Standardized and simplified nomenclature for proteins common to all retroviruses , 1988, Journal of virology.

[30]  B. Guy,et al.  HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product , 1987, Nature.

[31]  T. Copeland,et al.  Comparison of the HIV‐1 and HIV‐2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag‐Pol polyproteins , 1991, FEBS letters.

[32]  M. Bukrinsky,et al.  Anti-idiotypic antibody to the V3 domain of gp120 binds to vimentin: a possible role of intermediate filaments in the early steps of HIV-1 infection cycle. , 1996, Viral immunology.

[33]  S. Shaltiel,et al.  Phosphorylation of vitronectin on Ser362 by protein kinase C attenuates its cleavage by plasmin. , 1997, European journal of biochemistry.

[34]  J. Louis,et al.  Kinetic and modeling studies of S3-S3' subsites of HIV proteinases. , 1992, Biochemistry.

[35]  J. Tözsér,et al.  Comparison of the specificity of homo- and heterodimeric linked HIV-1 and HIV-2 proteinase dimers. , 1998, Protein engineering.

[36]  A Wlodawer,et al.  X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[37]  D. Grobelny,et al.  Selective phosphinate transition-state analogue inhibitors of the protease of human immunodeficiency virus. , 1990, Biochemical and biophysical research communications.

[38]  M. Inagaki,et al.  Site-specific phosphorylation induces disassembly of vimentin filaments in vitro , 1987, Nature.

[39]  F. Jensen,et al.  Association of ERK2 mitogen-activated protein kinase with human immunodeficiency virus particles , 1997, Journal of virology.

[40]  I. Weber,et al.  Comparative Studies on the Substrate Specificity of Avian Myeloblastosis Virus Proteinase and Lentiviral Proteinases (*) , 1996, The Journal of Biological Chemistry.

[41]  P. Tompa,et al.  Mutual protection of microtubule‐associated protein 2 (MAP2) and cyclic AMP‐dependent protein kinase II against μ‐calpain , 1996, Journal of neuroscience research.

[42]  T. Copeland,et al.  Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24 , 1988, Journal of virology.

[43]  I. Weber,et al.  Studies on the role of the S4 substrate binding site of HIV proteinases , 1991, FEBS letters.